Form 4: Amgen SVP Grygiel Reports Stock Disposition

Amgen's Senior Vice President and Chief Compliance Officer, Nancy A. Grygiel, reported the disposition of 787 shares of common stock at $366.21 per share.

Summary

• Nancy A. Grygiel, Amgen's Senior Vice President and Chief Compliance Officer, reported a disposition of 787 shares of Amgen common stock.
• The transaction occurred on March 16, 2026, at a price of $366.21 per share.
• Following this transaction, Grygiel directly beneficially owns 8,488 shares of common stock.
• An additional 106.1873 shares are indirectly owned through the company's 401(k) Plan.
• The disposed shares were related to the payment of tax liability incident to the vesting of a security, indicated by Transaction Code 'F'.
• Directly owned shares include 122 Dividend Equivalents (DEs) credited to unvested Restricted Stock Units, which are paid out in shares upon vesting according to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a standard insider transaction for tax purposes related to equity compensation, with no direct implications for the company's operational performance or future prospects.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding Amgen's future performance or strategic outlook.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to tax withholding upon the vesting of equity awards, are common and generally not indicative of a change in company fundamentals or broader industry trends. This specific transaction reflects a routine compensation event for a senior executive in the biotechnology sector.

Related Party Transactions

• Disposition of shares by SVP & CCO Nancy A. Grygiel, related to tax liability from equity awards granted under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan.

Stakeholder Impact

• Minimal direct impact on shareholders as this is a routine insider transaction for tax purposes, not indicative of a change in company fundamentals or strategic direction.

Key Dates

Recommendation

This Form 4 filing details a routine disposition of shares by a senior executive for tax withholding purposes upon the vesting of equity awards. Such transactions are common and do not typically signal a change in the company's fundamental outlook or warrant a shift in investment strategy. Therefore, a 'hold' recommendation is appropriate as this event does not provide new information to alter an existing investment thesis.

Keywords

Amgen, AMGN, Insider Transaction, Form 4, Stock Disposition, Nancy A. Grygiel, SVP, CCO, Equity Compensation, Restricted Stock Units, 401(k) Plan